Abstract

This Article examines the emergence of two modern pharmaceutical companies: Myriad and Moderna. After providing a brief background on each company, this Article contrasts them across the following areas: the technologies they have brought to market; their location; their start-up stages and the role that venture capital played in catalyzing their evolution from start-ups to large corporate structures; their relationships with other entities in the private sector, in academia and in the public sector; and their intellectual property and licensing strategies.

ISSN

2572-7044 (print) 2572-7117 (online)

DOI

https://doi.org/10.37419/JPL.V11.I1.3

Additional Information

Fall 2023 Symposium Issue

Keywords

Pharmaceutical Company, Intellectual Property

Disciplines

Health Law and Policy | Intellectual Property Law | Law | Property Law and Real Estate

Download

Share

COinS